Shattuck Labs, Inc.
STTKNasdaqCIK 1680367HealthcareFiscal year ends Dec 31
Reports and events: 97 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1106:59 ET | 8-K | 2.02 Results of operations | 0001628280-26-055484 |
| 2026-08-1106:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055483 |
| 2026-07-1721:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-084768 |
| 2026-06-1518:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000624 |
| 2026-06-1121:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-073086 |
| 2026-06-1108:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-266745 |
| 2026-06-0916:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-263831 |
| 2026-06-0217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-253784 |
| 2026-05-0706:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031661 |
| 2026-05-0706:34 ET | 8-K | 2.02 Results of operations | 0001628280-26-031643 |
| 2026-04-0806:30 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001193125-26-146293 |
| 2026-03-0506:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-014989 |
| 2026-03-0506:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-014987 |
| 2026-02-0516:30 ET | 8-K | 8.01 Other events | 0001193125-26-039488 |
| 2026-01-2217:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-019682 |
| 2025-11-0617:15 ET | 8-K/A | 2.02 Results of operations | 0001680367-25-000060 |
| 2025-11-0616:34 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001680367-25-000057 |
| 2025-11-0616:32 ET | 8-K | 2.02 Results of operations | 0001680367-25-000056 |
| 2025-09-0221:53 ET | SCHEDULE 13D | Ownership report, active investor | 0000947871-25-000841 |
| 2025-08-2617:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-083135 |
| 2025-08-2606:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-188078 |
| 2025-08-1406:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001680367-25-000046 |
| 2025-08-1406:37 ET | 8-K | 2.02 Results of operations | 0001680367-25-000044 |
| 2025-08-0621:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-074849 |
| 2025-08-0506:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-173010 |
| 2025-07-1516:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-159387 |
| 2025-05-2106:12 ET | DEF 14A | Proxy statementPeriod 2025-07-10 | 0001193125-25-123592 |
| 2025-05-0116:28 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001680367-25-000034 |
| 2025-05-0116:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-25-000030 |
| 2025-05-0116:14 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001680367-25-000028 |
| 2025-04-3007:12 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001680367-25-000017 |
| 2025-03-2707:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001680367-25-000012 |
| 2025-03-2707:03 ET | 8-K | 2.02 Results of operations | 0001680367-25-000009 |
| 2024-12-0621:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-126423 |
| 2024-11-1407:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001680367-24-000053 |
| 2024-11-1407:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-24-000050 |
| 2024-10-0106:36 ET | 8-K | 1.02 Termination of a material agreement; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-229480 |
| 2024-08-0116:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001680367-24-000040 |
| 2024-08-0116:14 ET | 8-K | 2.02 Results of operations | 0001680367-24-000038 |
| 2024-06-1406:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-161087 |
| 2024-06-1116:31 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-24-159174 |
| 2024-06-1016:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-158369 |
| 2024-05-0207:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001680367-24-000025 |
| 2024-05-0207:00 ET | 8-K | 2.02 Results of operations | 0001680367-24-000024 |
| 2024-04-2316:30 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001193125-24-107111 |
| 2024-03-0407:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-056839 |
| 2024-02-2916:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001680367-24-000014 |
| 2024-02-2916:07 ET | 8-K | 2.02 Results of operations | 0001680367-24-000012 |
| 2024-02-1306:07 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-032780 |
| 2023-12-2616:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-129205 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.